Cystic Fibrosis (CF) is the most frequent, lethal genetic disorder, affecting roughly 30,000 people in the United States. Early…
admin
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by admin
The Food and Drug Administration (FDA) has given a Humanitarian Use Device approval to a novel device, the XPSâ„¢ and…
Cystic Fibrosis Patients At Risk From Bacterial Strains Resistant To Antibodies, According To Study
Cystic Fibrosis is a serious genetic disease, with 1,000 new cases registered each year and more than 30,000 people…
Biopharmaceutical company AbbVie and the non-profit organization Cystic Fibrosis Research, Inc. (CFRI) recently announced a new partnership at…
The majority of patients suffering from cystic fibrosis (between 80-90% of the patient population) are affected by exocrine…
Experimental Drug For the Treatment of CF May Lead to Potential Treatment of CF-related Diabetes
With more than half of the patients with cystic fibrosis developing diabetes and most of them exhibiting insulin insufficiency,…
A team of researchers from the University of Pittsburgh has discovered that people with unexplained pancreatic problems might have…
Sick children under 12 years old needing a lung transplant, and who were previously almost totally dependent on lung…
Following the recent success of a phase 3b clinical trial for Aztreonam in cystic fibrosis (CF) patients with…
A recent study led by GBI Research entitled “Cystic Fibrosis Therapeutics in Major Developed Markets 2019 – CFTR Modulators…